• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从小鼠肝脏中克隆过氧化物酶体增殖物激活受体基因家族的一个新成员。

Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

作者信息

Zhu Y, Alvares K, Huang Q, Rao M S, Reddy J K

机构信息

Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

J Biol Chem. 1993 Dec 25;268(36):26817-20.

PMID:8262913
Abstract

Peroxisome proliferators are postulated to elicit predictable pleiotropic responses in the liver by activating a peroxisome proliferator-activated receptor (PPAR). PPARs from mouse liver (mPPAR), rat liver (rPPAR), and Xenopus liver (xPPAR gamma) have been cloned recently. We now report the cloning of a new member from mouse liver which we designate mPPAR gamma. mPPAR gamma cDNA contained an open reading frame encoding a 475-amino acid protein exhibiting 75% amino acid similarity to xPPAR gamma, while it showed only 55% identity with mPPAR. The ligand-binding and DNA-binding domains are best conserved between mPPAR gamma, mPPAR, and xPPAR gamma. Like rPPAR, mPPAR gamma is able to impart peroxisome proliferator responsiveness to the promoter of peroxisomal bifunctional gene, which encodes the second enzyme of the peroxisomal fatty acid beta-oxidation system. Northern blot analysis revealed high expression of mPPAR gamma gene in mouse liver, kidney, and heart and low expression in the lung, testis, brain, skeletal muscle, and spleen. In mice treated with ciprofibrate, a peroxisome proliferator, a 2-fold increase in mPPAR gamma mRNA was observed in the liver and kidney. The presence of two PPARs in the mouse liver suggests the possibility of multiple signaling pathways for the peroxisome proliferator-induced pleiotropic responses.

摘要

过氧化物酶体增殖剂被假定通过激活过氧化物酶体增殖剂激活受体(PPAR)在肝脏中引发可预测的多效性反应。来自小鼠肝脏(mPPAR)、大鼠肝脏(rPPAR)和非洲爪蟾肝脏(xPPARγ)的PPARs最近已被克隆。我们现在报告从小鼠肝脏中克隆出一个新成员,我们将其命名为mPPARγ。mPPARγ cDNA包含一个开放阅读框,编码一种475个氨基酸的蛋白质,与xPPARγ的氨基酸相似性为75%,而与mPPAR的同一性仅为55%。mPPARγ、mPPAR和xPPARγ之间的配体结合域和DNA结合域保守性最佳。与rPPAR一样,mPPARγ能够赋予过氧化物酶体增殖剂对过氧化物酶体双功能基因启动子的反应性,该基因编码过氧化物酶体脂肪酸β-氧化系统的第二种酶。Northern印迹分析显示,mPPARγ基因在小鼠肝脏、肾脏和心脏中高表达,在肺、睾丸、脑、骨骼肌和脾脏中低表达。在用过氧化物酶体增殖剂环丙贝特处理的小鼠中,肝脏和肾脏中的mPPARγ mRNA增加了2倍。小鼠肝脏中存在两种PPARs,这表明过氧化物酶体增殖剂诱导的多效性反应可能存在多种信号通路。

相似文献

1
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.从小鼠肝脏中克隆过氧化物酶体增殖物激活受体基因家族的一个新成员。
J Biol Chem. 1993 Dec 25;268(36):26817-20.
2
cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPAR gamma.仓鼠过氧化物酶体增殖物激活受体haPPARγ的cDNA克隆及其转录活性的表征
Gene. 1995 Sep 11;162(2):297-302. doi: 10.1016/0378-1119(95)00196-d.
3
Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms.小鼠过氧化物酶体增殖物激活受体γ(mPPARγ)基因的结构组织:不同启动子的使用和不同的剪接产生两种mPPARγ亚型。
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7921-5. doi: 10.1073/pnas.92.17.7921.
4
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.mPPARγ2:脂肪细胞增强子的组织特异性调节因子。
Genes Dev. 1994 May 15;8(10):1224-34. doi: 10.1101/gad.8.10.1224.
5
Identification of two mPPAR related receptors and evidence for the existence of five subfamily members.两种与小鼠过氧化物酶体增殖物激活受体(mPPAR)相关的受体的鉴定以及五个亚家族成员存在的证据。
Biochem Biophys Res Commun. 1993 Oct 29;196(2):671-7. doi: 10.1006/bbrc.1993.2302.
6
Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression.多种过氧化物酶体增殖物激活受体可与大鼠水化酶/脱氢酶及脂肪酰辅酶A氧化酶基因的过氧化物酶体增殖物反应元件结合,但诱导表达的方式存在差异。
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5723-7. doi: 10.1073/pnas.90.12.5723.
7
Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.人和大鼠的过氧化物酶体增殖物激活受体(PPARs)表现出相似的组织分布,但对PPAR激活剂的反应性不同。
J Steroid Biochem Mol Biol. 1994 Nov;51(3-4):157-66. doi: 10.1016/0960-0760(94)90089-2.
8
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.在小鼠中对过氧化物酶体增殖物激活受体基因的α亚型进行靶向破坏,会导致过氧化物酶体增殖物的多效性作用消失。
Mol Cell Biol. 1995 Jun;15(6):3012-22. doi: 10.1128/MCB.15.6.3012.
9
Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids.非洲爪蟾过氧化物酶体增殖物激活受体:基因组结构、反应元件识别、与视黄酸X受体形成异源二聚体以及脂肪酸激活
J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):65-73. doi: 10.1016/0960-0760(93)90058-5.
10
A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.小鼠过氧化物酶体增殖物激活受体α中的单个氨基酸变化改变了对过氧化物酶体增殖物的转录反应。
Mol Pharmacol. 1995 Sep;48(3):559-67.

引用本文的文献

1
Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development.非酒精性脂肪性肝病中PPARγ的治疗靶点:疗效、安全性与药物研发
Drug Des Devel Ther. 2025 Aug 22;19:7293-7319. doi: 10.2147/DDDT.S524893. eCollection 2025.
2
Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPARγ signaling pathway and gut microbiota in mice.五味子乙素通过调节小鼠的PPARγ信号通路和肠道微生物群来减轻代谢相关脂肪性肝病。
Front Pharmacol. 2025 Jul 25;16:1583307. doi: 10.3389/fphar.2025.1583307. eCollection 2025.
3
Hepatic Lipidomics Unravels the Lipid-Lowering and Anti-Obesity Efficacy of Diacylglycerol Oil: Mechanistic Insights From High-Fat Diet-Induced Obese Mice.
肝脏脂质组学揭示二酰甘油油的降脂和抗肥胖功效:来自高脂饮食诱导的肥胖小鼠的机制见解
Food Sci Nutr. 2025 Jun 13;13(6):e70395. doi: 10.1002/fsn3.70395. eCollection 2025 Jun.
4
Rosiglitazone Promotes Oligodendrocyte Development and Myelin Formation of Repeated Neonatal Sevoflurane Exposure via PPARγ Signaling.罗格列酮通过PPARγ信号通路促进反复新生期七氟醚暴露后的少突胶质细胞发育和髓鞘形成。
Mol Neurobiol. 2025 Feb;62(2):2348-2361. doi: 10.1007/s12035-024-04413-z. Epub 2024 Aug 6.
5
Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.过氧化物酶体增殖物激活受体靶向治疗:感染性疾病面临的挑战。
Cells. 2023 Feb 17;12(4):650. doi: 10.3390/cells12040650.
6
Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease.肝脏过氧化物酶体增殖物激活受体 γ 在非酒精性脂肪性肝病中的作用。
J Endocrinol. 2023 Mar 10;257(1). doi: 10.1530/JOE-22-0155. Print 2023 Apr 1.
7
PPARγ attenuates hepatic inflammation and oxidative stress of non‑alcoholic steatohepatitis via modulating the miR‑21‑5p/SFRP5 pathway.过氧化物酶体增殖物激活受体 γ 通过调节 miR-21-5p/SFRP5 通路减轻非酒精性脂肪性肝炎的肝炎症和氧化应激。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12463. Epub 2021 Sep 24.
8
PPAR Gamma and Viral Infections of the Brain.过氧化物酶体增殖物激活受体γ与脑部病毒感染
Int J Mol Sci. 2021 Aug 18;22(16):8876. doi: 10.3390/ijms22168876.
9
Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγ.四氢黄腐醇,一种黄腐酚衍生物,通过拮抗 PPARγ 来减轻高脂饮食诱导的肝脂肪变性。
Elife. 2021 Jun 15;10:e66398. doi: 10.7554/eLife.66398.
10
PPARs and Microbiota in Skeletal Muscle Health and Wasting.过氧化物酶体增殖物激活受体(PPARs)与骨骼肌健康和消耗中的微生物群。
Int J Mol Sci. 2020 Oct 29;21(21):8056. doi: 10.3390/ijms21218056.